3 Stocks Pushing The Health Services Industry Downward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 7 points (0.0%) at 17,094 as of Thursday, July 24, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,609 issues advancing vs. 1,334 declining with 169 unchanged.

The Health Services industry currently sits up 0.2% versus the S&P 500, which is up 0.1%. Top gainers within the industry include Chemed ( CHE), up 4.8%, Health Net ( HNT), up 4.3%, Cooper Companies ( COO), up 1.8%, Universal Health Services ( UHS), up 1.2% and Fresenius Medical Care AG & Co. KGaA ( FMS), up 0.8%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Invacare ( IVC) is one of the companies pushing the Health Services industry lower today. As of noon trading, Invacare is down $2.60 (-14.8%) to $14.98 on heavy volume. Thus far, 439,928 shares of Invacare exchanged hands as compared to its average daily volume of 179,800 shares. The stock has ranged in price between $14.88-$17.33 after having opened the day at $17.20 as compared to the previous trading day's close of $17.58.

Invacare Corporation designs, manufactures, and distributes medical equipment and supplies worldwide. The company operates through four segments: North America/Home Medical Equipment, Institutional Products Group, Europe, and Asia/Pacific. Invacare has a market cap of $553.6 million and is part of the health care sector. Shares are down 24.3% year-to-date as of the close of trading on Wednesday. Currently there are no analysts that rate Invacare a buy, no analysts rate it a sell, and 1 rates it a hold.

TheStreet Ratings rates Invacare as a hold. The company's strengths can be seen in multiple areas, such as its good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and poor profit margins. Get the full Invacare Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Varian Medical Systems ( VAR) is down $5.32 (-6.1%) to $82.20 on heavy volume. Thus far, 1.2 million shares of Varian Medical Systems exchanged hands as compared to its average daily volume of 598,700 shares. The stock has ranged in price between $82.19-$85.25 after having opened the day at $84.40 as compared to the previous trading day's close of $87.52.

Varian Medical Systems, Inc. designs, manufactures, sells, and services medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy worldwide. Varian Medical Systems has a market cap of $8.8 billion and is part of the health care sector. Shares are up 12.7% year-to-date as of the close of trading on Wednesday. Currently there are 7 analysts that rate Varian Medical Systems a buy, 1 analyst rates it a sell, and none rate it a hold.

TheStreet Ratings rates Varian Medical Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Varian Medical Systems Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Stryker Corporation ( SYK) is down $0.97 (-1.2%) to $80.84 on heavy volume. Thus far, 1.5 million shares of Stryker Corporation exchanged hands as compared to its average daily volume of 1.5 million shares. The stock has ranged in price between $80.55-$81.88 after having opened the day at $81.88 as compared to the previous trading day's close of $81.81.

Stryker Corporation, together with its subsidiaries, operates as a medical technology company. The company operates in three segments: Reconstructive, MedSurg, and Neurotechnology and Spine. Stryker Corporation has a market cap of $31.2 billion and is part of the health care sector. Shares are up 8.9% year-to-date as of the close of trading on Wednesday. Currently there are 14 analysts that rate Stryker Corporation a buy, no analysts rate it a sell, and 9 rate it a hold.

TheStreet Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, increase in net income, good cash flow from operations and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Stryker Corporation Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

null

More from Markets

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

McKesson Internal Review Clears Senior Management of Wrongdoing on Opioids

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Starbucks Surprises Wall Street With U.S. Sales Up a Paltry 2%

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Dow Jumps 238 Points as S&P 500, Nasdaq Also Climb

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

Why Nashville, Denver, LA Should Reconsider Bids for Amazon HQ2

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists